A tailored course, built for your situation
Risk-Managed AI in Pharmaceutical R&D Operations for Compliance Officers
Master compliant, governance-aligned AI integration in drug development
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
AI is accelerating drug discovery, but compliance teams are being asked to assess systems they weren’t trained to evaluate.
The situation this course is for
Pharmaceutical compliance officers face increasing pressure to validate AI-driven R&D processes without clear governance standards, consistent evaluation frameworks, or internal expertise. Traditional compliance playbooks don’t address model drift, training data provenance, or algorithmic auditability, yet these are now central to regulatory scrutiny.
Who this is for
Compliance and governance professionals in pharmaceutical or life sciences organizations responsible for validating, auditing, or approving AI-enabled R&D processes.
Who this is not for
This course is not for data scientists building models, nor for executives seeking high-level overviews. It is designed specifically for compliance officers who need to implement and enforce controls, not design algorithms.
What you walk away with
- Evaluate AI systems in R&D using regulatory-aligned risk assessment frameworks
- Apply model governance checklists tailored to pharmaceutical development cycles
- Identify and document compliance exposure in AI training data pipelines
- Implement audit-ready documentation practices for algorithmic decision traces
- Lead cross-functional alignment between R&D, legal, and compliance teams on AI governance
The 12 modules (with all 144 chapters)
Module 1. The Evolving Role of Compliance in AI-Driven R&D
Understand how compliance functions are shifting from reactive oversight to proactive governance in AI-enabled drug development.
12 chapters in this module
- From gatekeeper to enabler: new compliance mandates
- AI adoption trends in preclinical research
- Regulatory expectations evolving with technology
- The rise of algorithmic accountability
- Compliance as innovation catalyst
- Mapping AI use cases in pharma R&D
- Key regulatory bodies and their AI positions
- Defining 'responsible AI' in drug development
- Compliance team structure evolution
- Cross-functional collaboration models
- Documenting AI governance authority
- Integrating compliance into AI project lifecycles
Module 2. Foundations of AI in Pharmaceutical Research
Build technical fluency in AI methods used in drug discovery and development workflows.
12 chapters in this module
- Machine learning vs. traditional statistical methods
- Supervised learning in clinical trial design
- Unsupervised learning for biomarker discovery
- Natural language processing in literature review
- Deep learning in molecular modeling
- Reinforcement learning in dose optimization
- AI in high-throughput screening
- Model inputs and data requirements
- Understanding model confidence intervals
- AI lifecycle stages in pharma
- Model retraining triggers
- Version control for AI systems
Module 3. Regulatory Frameworks for AI in Drug Development
Navigate global compliance requirements affecting AI use in pharmaceutical R&D.
12 chapters in this module
- FDA guidance on AI/ML in medical products
- EMA perspective on algorithmic transparency
- ICH guidelines and AI adaptation
- 21 CFR Part 11 and electronic records
- GDPR implications for training data
- HIPAA considerations in clinical AI
- Data provenance and audit trails
- Global alignment and divergence points
- Regulatory submission requirements
- Inspection readiness for AI systems
- Labeling AI-assisted decision tools
- Post-market surveillance for adaptive models
Module 4. AI Risk Assessment for Compliance Officers
Apply structured risk evaluation methods to AI systems in R&D contexts.
12 chapters in this module
- Risk domains in AI-driven R&D
- Identifying high-risk AI applications
- Model explainability requirements
- Bias detection in training data
- Data quality and representativeness
- Model performance thresholds
- Third-party AI vendor risk
- Supply chain transparency
- Cybersecurity implications
- Model drift and degradation
- Failure impact categorization
- Risk scoring methodology
Module 5. Governance Architecture for AI Systems
Design and implement governance structures that ensure AI compliance across R&D phases.
12 chapters in this module
- AI governance committee design
- Roles and responsibilities matrix
- Approval workflows for model deployment
- Change control for AI updates
- Documentation standards
- Audit trail requirements
- Model version tracking
- Data lineage mapping
- Ethics review integration
- Stakeholder communication plans
- Escalation pathways
- Governance tooling options
Module 6. Model Validation and Verification
Ensure AI systems meet scientific, regulatory, and operational standards.
12 chapters in this module
- Validation vs. verification distinctions
- Preclinical model validation
- Clinical trial support system checks
- Algorithmic reproducibility
- Statistical soundness assessment
- Reference data set requirements
- Cross-validation strategies
- Sensitivity analysis
- Robustness testing
- Adversarial testing basics
- Model uncertainty quantification
- Validation documentation templates
Module 7. Data Compliance in AI Training Pipelines
Ensure training data meets regulatory and ethical standards.
12 chapters in this module
- Data sourcing ethics
- Patient data consent frameworks
- De-identification standards
- Data use agreements
- Data provenance tracking
- Bias mitigation in dataset curation
- Data quality audits
- Data refresh protocols
- Multinational data transfer rules
- Data retention policies
- Third-party data vendor oversight
- Data lineage documentation
Module 8. Explainability and Auditability of AI Models
Ensure AI decisions can be understood, challenged, and reviewed.
12 chapters in this module
- Regulatory need for explainability
- Global explainability standards
- Model interpretability techniques
- Local vs. global explanations
- SHAP and LIME applications
- Decision trace documentation
- Audit trail design
- Human-in-the-loop requirements
- Right to explanation frameworks
- Explainability in regulatory submissions
- Model card creation
- Explainability testing protocols
Module 9. AI in Clinical Trial Design and Monitoring
Apply compliance oversight to AI-enhanced trial methodologies.
12 chapters in this module
- AI for patient recruitment
- Site selection optimization
- Adaptive trial design
- Endpoint prediction models
- Safety signal detection
- Protocol deviation analysis
- Real-world data integration
- Patient-reported outcome analysis
- AI-assisted monitoring
- Blinding integrity
- Data monitoring committee roles
- Regulatory reporting triggers
Module 10. Third-Party AI Vendor Management
Govern AI solutions developed or hosted by external partners.
12 chapters in this module
- Vendor due diligence checklist
- Contractual compliance terms
- Data ownership clauses
- Model access rights
- Right-to-audit provisions
- Security certification requirements
- Service level agreements
- Change notification obligations
- Subcontractor oversight
- Exit strategy planning
- Vendor performance monitoring
- Compliance validation workflow
Module 11. Change Management for AI Systems
Manage updates, retraining, and deactivation of AI models in compliance with regulations.
12 chapters in this module
- Model lifecycle phases
- Retraining triggers
- Performance degradation thresholds
- Version control protocols
- Change approval workflows
- Rollback procedures
- Notification requirements
- Regulatory update submissions
- User communication plans
- Training updates for end users
- Documentation updates
- Post-change validation
Module 12. Leading AI Compliance Transformation
Drive organizational change to institutionalize AI governance.
12 chapters in this module
- Building AI compliance capability
- Training program design
- Internal audit readiness
- Compliance maturity assessment
- Benchmarking against peers
- Board-level reporting
- KPIs for AI governance
- Lessons from enforcement actions
- Future-proofing compliance frameworks
- AI governance policy templates
- Cross-industry insights
- Sustaining compliance excellence
How this maps to your situation
- Assessing AI use in early-stage drug discovery
- Validating AI models in clinical development
- Auditing third-party AI vendors in pharma supply chains
- Preparing for regulatory inspections of AI systems
Before vs. after
Before
Overwhelmed by technical AI concepts and unclear compliance expectations in fast-moving R&D environments.
After
Confidently leading AI governance initiatives, equipped with practical frameworks, audit tools, and regulatory alignment strategies.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 4-6 hours per module. Designed for professionals balancing full-time roles. Self-paced with structured progression.
If nothing changes
Without structured governance, AI adoption in R&D may outpace compliance readiness, leading to regulatory scrutiny, audit findings, or reputational exposure, especially as agencies increase focus on algorithmic transparency.
How this compares to the alternatives
Unlike generic AI ethics courses or technical data science programs, this course is purpose-built for pharmaceutical compliance officers, focusing on implementation-grade governance, regulatory alignment, and R&D-specific risk patterns.
Frequently asked
Who is this course designed for?
Compliance, quality assurance, and regulatory affairs professionals in pharmaceutical and life sciences organizations who need to govern AI systems in R&D.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is this course technical?
It assumes no programming background but builds strong conceptual and governance-level fluency in AI systems used in drug development.
$199 one-time. Approximately 4-6 hours per module. Designed for professionals balancing full-time roles. Self-paced with structured progression..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours